These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26306696)

  • 41. Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm.
    Karp BI; Alter K
    Semin Neurol; 2016 Feb; 36(1):84-91. PubMed ID: 26866500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dystonia and its disorders.
    Friedman J; Standaert DG
    Neurol Clin; 2001 Aug; 19(3):681-705, vii. PubMed ID: 11532649
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-motor symptoms in patients with adult-onset focal dystonia: Sensory and psychiatric disturbances.
    Conte A; Berardelli I; Ferrazzano G; Pasquini M; Berardelli A; Fabbrini G
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S111-4. PubMed ID: 26360238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The epidemiology of primary dystonia: current evidence and perspectives.
    Defazio G
    Eur J Neurol; 2010 Jul; 17 Suppl 1():9-14. PubMed ID: 20590802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sonographic Alteration of Basal Ganglia in Different Forms of Primary Focal Dystonia: A Cross-sectional Study.
    Zhang Y; Zhang YC; Sheng YJ; Chen XF; Wang CS; Ma Q; Chen HB; Yu LF; Mao CJ; Xiong KP; Luo WF; Liu CF
    Chin Med J (Engl); 2016 Apr; 129(8):942-5. PubMed ID: 27064039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of primary focal and segmental dystonia in Oslo.
    Le KD; Nilsen B; Dietrichs E
    Neurology; 2003 Nov; 61(9):1294-6. PubMed ID: 14610144
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adult-onset focal dystonias: presentation and treatment options.
    Esper GJ; Charles PD; Davis TL; Robertson D
    Tenn Med; 1997 Jan; 90(1):18-20. PubMed ID: 8997156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The environmental epidemiology of primary dystonia.
    Defazio G; Gigante AF
    Tremor Other Hyperkinet Mov (N Y); 2013; 3():. PubMed ID: 23724359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term assessment of the risk of spread in primary late-onset focal dystonia.
    Abbruzzese G; Berardelli A; Girlanda P; Marchese R; Martino D; Morgante F; Avanzino L; Colosimo C; Defazio G
    J Neurol Neurosurg Psychiatry; 2008 Apr; 79(4):392-6. PubMed ID: 17635969
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic delay in adult-onset dystonia: data from an Italian movement disorder center.
    Macerollo A; Superbo M; Gigante AF; Livrea P; Defazio G
    J Clin Neurosci; 2015 Mar; 22(3):608-10. PubMed ID: 25577433
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenotype of the DYT1 mutation in the TOR1A gene in a Polish population of patients with dystonia. A preliminary report.
    Gajos A; Piaskowski S; Sławek J; Ochudło S; Opala G; Łobińska A; Honczarenko K; Budrewicz S; Koszewicz M; Pełszyńska B; Liberski PP; Bogucki A
    Neurol Neurochir Pol; 2007; 41(6):487-94. PubMed ID: 18224570
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation and treatment of dystonia.
    Scott BL
    South Med J; 2000 Aug; 93(8):746-51. PubMed ID: 10963502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and genetic evaluation in a French population presenting with primary focal dystonia.
    Dhaenens CM; Krystkowiak P; Douay X; Charpentier P; Bele S; Destée A; Sablonnière B
    Mov Disord; 2005 Jul; 20(7):822-5. PubMed ID: 15726581
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Botulinum neurotoxins for the treatment of focal dystonias: Review of rating tools used in clinical trials.
    Del Sorbo F; Albanese A
    Toxicon; 2015 Dec; 107(Pt A):89-97. PubMed ID: 26365917
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of focal dystonia with botulinic toxin].
    Gracia F; Castillo LC
    Rev Med Panama; 1996 Sep; 21(3):121-31. PubMed ID: 9280925
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frequency of familial aggregation in primary adult-onset cranial cervical dystonia.
    Defazio G; Aniello MS; Masi G; Lucchese V; De Candia D; Martino D
    Neurol Sci; 2003 Oct; 24(3):168-9. PubMed ID: 14598070
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors for spread of primary adult onset blepharospasm: a multicentre investigation of the Italian movement disorders study group.
    Defazio G; Berardelli A; Abbruzzese G; Coviello V; Carella F; De Berardinis MT; Galardi G; Girlanda P; Maurri S; Mucchiut M; Albanese A; Basciani M; Bertolasi L; Liguori R; Tambasco N; Santoro L; Assennato G; Livrea P
    J Neurol Neurosurg Psychiatry; 1999 Nov; 67(5):613-9. PubMed ID: 10519867
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Dystonias: what the practitioner needs to know].
    von Dengler R; Rollnik JD
    MMW Fortschr Med; 2004 Nov; 146(48):44-6. PubMed ID: 15625936
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Botulinum toxins in the treatment of primary focal dystonias.
    Truong D
    J Neurol Sci; 2012 May; 316(1-2):9-14. PubMed ID: 22336699
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Prevalence of Idiopathic or Inherited Isolated Dystonia: A Systematic Review and Meta-Analysis.
    Medina A; Nilles C; Martino D; Pelletier C; Pringsheim T
    Mov Disord Clin Pract; 2022 Oct; 9(7):860-868. PubMed ID: 36247920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.